← Back
$CORT All transactions

CORCEPT THERAPEUTICS INC

M

$ Value

$19K

Shares

5,000

Price

$4

Filed

Aug 26

Insider

Name

Robb Gary Charles

Title

Chief Business Officer

CIK

0001529655

Roles

Officer

Transaction Details

Transaction Date

2025-08-22

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

18,364

Footnotes

Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. | These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options. | These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. | These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. | Fully exercisable.

Filing Info

Accession No.

0001193125-25-188869

Form Type

4

Issuer CIK

0001088856

Robb Gary Charles's History

Date Ticker Type Value
2025-12-24 CORT M $563K
2025-12-24 CORT F $6.7M
2025-12-24 CORT M $0
2025-12-02 CORT F $12K
2025-12-01 CORT A $18K
2025-12-01 CORT A $0
2025-09-03 CORT F $18K
2025-09-02 CORT A $18K
2025-09-02 CORT A $0
2025-08-22 CORT M $19K

Other Insiders at CORT (90d)

Insider Bought Sold Last
BAKER G LEONARD JR 2026-01-27
WILSON JAMES N 2026-04-06
BELANOFF JOSEPH K
Chief Executive Officer
$1.3M 2026-03-25
Hunt Hazel
Chief Scientific Officer
2026-02-09
Guyer William
Chief Development Officer
$2.1M 2026-04-07